Clinical Trial-Clinical Trial Center, Kaohsiung Medical University Chung-Ho Memorial Hospital

Trial Section

  Home / Trial Section / Clinical Trial
Indication Department Study Title Study Phase Investigator Contact Person Status
General and Digestive Surgery FGFR2/FOXM1-mediated acquisition of regorafenib resistance and liver cancer stem cells -- Kung-Kai Kuo 楊雅涵 On-going
Liver Cancer General and Digestive Surgery REFINE: Regorafenib Observational Study in Hepatocellular Carcinoma Phase IV Kung-Kai Kuo 王怡婷 Completed

 ←   Please slide to the left for more information